Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 181 to 187 of 187 entries
Sorted by: Best Match Show Resources per page
Modulation of the gut microbiota by prebiotic fibres and bacteriocins.

Microbial ecology in health and disease

Umu ÖCO, Rudi K, Diep DB.
PMID: 28959178
Microb Ecol Health Dis. 2017 Jan 01;28(1):1348886. doi: 10.1080/16512235.2017.1348886. eCollection 2017.

The gut microbiota is considered an organ that co-develops with the host throughout its life. The composition and metabolic activities of the gut microbiota are subject to a complex interplay between the host genetics and environmental factors, such as...

Cite
Umu ÖCO, Rudi K, Diep DB. Modulation of the gut microbiota by prebiotic fibres and bacteriocins. Microb Ecol Health Dis. 2017;28(1):1348886doi: 10.1080/16512235.2017.1348886.
Umu, �. �. C. O., Rudi, K., & Diep, D. B. (2017). Modulation of the gut microbiota by prebiotic fibres and bacteriocins. Microbial ecology in health and disease, 28(1), 1348886. https://doi.org/10.1080/16512235.2017.1348886
Umu, Özgün C O, et al. "Modulation of the gut microbiota by prebiotic fibres and bacteriocins." Microbial ecology in health and disease vol. 28,1 (2017): 1348886. doi: https://doi.org/10.1080/16512235.2017.1348886
Umu ÖCO, Rudi K, Diep DB. Modulation of the gut microbiota by prebiotic fibres and bacteriocins. Microb Ecol Health Dis. 2017 Jan 01;28(1):1348886. doi: 10.1080/16512235.2017.1348886. eCollection 2017. PMID: 28959178; PMCID: PMC5614387.
Copy Download .nbib Format: NLM
Ubericin K, a New Pore-Forming Bacteriocin Targeting mannose-PTS.

Microbiology spectrum

Oftedal TF, Ovchinnikov KV, Hestad KA, Goldbeck O, Porcellato D, Narvhus J, Riedel CU, Kjos M, Diep DB.
PMID: 34643411
Microbiol Spectr. 2021 Oct 31;9(2):e0029921. doi: 10.1128/Spectrum.00299-21. Epub 2021 Oct 13.

Bovine mastitis infection in dairy cattle is a significant economic burden for the dairy industry globally. To reduce the use of antibiotics in treatment of clinical mastitis, new alternative treatment options are needed. Antimicrobial peptides from bacteria, also known...

Cite
Oftedal TF, Ovchinnikov KV, Hestad KA, et al. Ubericin K, a New Pore-Forming Bacteriocin Targeting mannose-PTS. Microbiol Spectr. 2021;9(2):e0029921doi: 10.1128/Spectrum.00299-21.
Oftedal, T. F., Ovchinnikov, K. V., Hestad, K. A., Goldbeck, O., Porcellato, D., Narvhus, J., Riedel, C. U., Kjos, M., & Diep, D. B. (2021). Ubericin K, a New Pore-Forming Bacteriocin Targeting mannose-PTS. Microbiology spectrum, 9(2), e0029921. https://doi.org/10.1128/Spectrum.00299-21
Oftedal, Thomas F, et al. "Ubericin K, a New Pore-Forming Bacteriocin Targeting mannose-PTS." Microbiology spectrum vol. 9,2 (2021): e0029921. doi: https://doi.org/10.1128/Spectrum.00299-21
Oftedal TF, Ovchinnikov KV, Hestad KA, Goldbeck O, Porcellato D, Narvhus J, Riedel CU, Kjos M, Diep DB. Ubericin K, a New Pore-Forming Bacteriocin Targeting mannose-PTS. Microbiol Spectr. 2021 Oct 31;9(2):e0029921. doi: 10.1128/Spectrum.00299-21. Epub 2021 Oct 13. PMID: 34643411; PMCID: PMC8515946.
Copy Download .nbib Format: NLM
Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alpha) spike.

bioRxiv : the preprint server for biology

Lubinski B, Fernandes MHV, Frazier L, Tang T, Daniel S, Diel DG, Jaimes JA, Whittaker GR.
PMID: 33851153
bioRxiv. 2021 Nov 01; doi: 10.1101/2021.04.06.438731.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the agent causing the COVID-19 pandemic. SARS-CoV-2 B.1.1.7 (Alpha), a WHO variant of concern (VOC) first identified in the UK in late 2020, contains several mutations including P681H in the spike...

Cite
Lubinski B, Fernandes MHV, Frazier L, et al. Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alpha) spike. bioRxiv. 2021;doi: 10.1101/2021.04.06.438731.
Lubinski, B., Fernandes, M. H. V., Frazier, L., Tang, T., Daniel, S., Diel, D. G., Jaimes, J. A., & Whittaker, G. R. (2021). Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alpha) spike. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.04.06.438731
Lubinski, Bailey, et al. "Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alpha) spike." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.04.06.438731
Lubinski B, Fernandes MHV, Frazier L, Tang T, Daniel S, Diel DG, Jaimes JA, Whittaker GR. Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alpha) spike. bioRxiv. 2021 Nov 01; doi: 10.1101/2021.04.06.438731. PMID: 33851153; PMCID: PMC8043443.
Copy Download .nbib Format: NLM
Age-related susceptibility of ferrets to SARS-CoV-2 infection.

Journal of virology

Martins M, Fernandes MHV, Joshi LR, Diel DG.
PMID: 34817200
J Virol. 2021 Nov 24;JVI0145521. doi: 10.1128/JVI.01455-21. Epub 2021 Nov 24.

Susceptibility to SARS-CoV-2 and the outcome of COVID-19 have been linked to underlying health conditions and the age of affected individuals. Here we assessed the effect of age on SARS-CoV-2 infection using a ferret model. For this, young (6-month-old)...

Cite
Martins M, Fernandes MHV, Joshi LR, et al. Age-related susceptibility of ferrets to SARS-CoV-2 infection. J Virol. 2021;JVI0145521doi: 10.1128/JVI.01455-21.
Martins, M., Fernandes, M. H. V., Joshi, L. R., & Diel, D. G. (2021). Age-related susceptibility of ferrets to SARS-CoV-2 infection. Journal of virology, JVI0145521. https://doi.org/10.1128/JVI.01455-21
Martins, Mathias, et al. "Age-related susceptibility of ferrets to SARS-CoV-2 infection." Journal of virology vol. (2021): JVI0145521. doi: https://doi.org/10.1128/JVI.01455-21
Martins M, Fernandes MHV, Joshi LR, Diel DG. Age-related susceptibility of ferrets to SARS-CoV-2 infection. J Virol. 2021 Nov 24;JVI0145521. doi: 10.1128/JVI.01455-21. Epub 2021 Nov 24. PMID: 34817200.
Copy Download .nbib Format: NLM
Stability of Senecavirus A in animal feed ingredients and infection following consumption of contaminated feed.

Transboundary and emerging diseases

C Caserta L, G Noll JC, Singrey A, Niederwerder MC, Dee S, Nelson EA, Diel DG.
PMID: 34473909
Transbound Emerg Dis. 2021 Sep 02; doi: 10.1111/tbed.14310. Epub 2021 Sep 02.

Animal feed and feed ingredients have recently been investigated as sources of pathogen introduction to farms and as a potential source of infection to animals post-consumption of contaminated feed. Survival of several viruses for a prolonged period has been...

Cite
C Caserta L, G Noll JC, Singrey A, et al. Stability of Senecavirus A in animal feed ingredients and infection following consumption of contaminated feed. Transbound Emerg Dis. 2021;doi: 10.1111/tbed.14310.
C Caserta, L., G Noll, J. C., Singrey, A., Niederwerder, M. C., Dee, S., Nelson, E. A., & Diel, D. G. (2021). Stability of Senecavirus A in animal feed ingredients and infection following consumption of contaminated feed. Transboundary and emerging diseases, . https://doi.org/10.1111/tbed.14310
C Caserta, Leonardo, et al. "Stability of Senecavirus A in animal feed ingredients and infection following consumption of contaminated feed." Transboundary and emerging diseases vol. (2021). doi: https://doi.org/10.1111/tbed.14310
C Caserta L, G Noll JC, Singrey A, Niederwerder MC, Dee S, Nelson EA, Diel DG. Stability of Senecavirus A in animal feed ingredients and infection following consumption of contaminated feed. Transbound Emerg Dis. 2021 Sep 02; doi: 10.1111/tbed.14310. Epub 2021 Sep 02. PMID: 34473909.
Copy Download .nbib Format: NLM
Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike.

iScience

Lubinski B, Fernandes MHV, Frazier L, Tang T, Daniel S, Diel DG, Jaimes JA, Whittaker GR.
PMID: 34909610
iScience. 2022 Jan 21;25(1):103589. doi: 10.1016/j.isci.2021.103589. Epub 2021 Dec 10.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the agent causing the COVID-19 pandemic. SARS-CoV-2 B.1.1.7 (Alpha), a WHO variant of concern first identified in the United Kingdom in late 2020, contains several mutations including P681H in the spike...

Cite
Lubinski B, Fernandes MHV, Frazier L, et al. Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike. iScience. 2021;25(1):103589doi: 10.1016/j.isci.2021.103589.
Lubinski, B., Fernandes, M. H. V., Frazier, L., Tang, T., Daniel, S., Diel, D. G., Jaimes, J. A., & Whittaker, G. R. (2022). Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike. iScience, 25(1), 103589. https://doi.org/10.1016/j.isci.2021.103589
Lubinski, Bailey, et al. "Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike." iScience vol. 25,1 (2022): 103589. doi: https://doi.org/10.1016/j.isci.2021.103589
Lubinski B, Fernandes MHV, Frazier L, Tang T, Daniel S, Diel DG, Jaimes JA, Whittaker GR. Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike. iScience. 2022 Jan 21;25(1):103589. doi: 10.1016/j.isci.2021.103589. Epub 2021 Dec 10. PMID: 34909610; PMCID: PMC8662955.
Copy Download .nbib Format: NLM
Staphylococcal Biofilms: Challenges and Novel Therapeutic Perspectives.

Antibiotics (Basel, Switzerland)

Kranjec C, Morales Angeles D, Torrissen Mårli M, Fernández L, García P, Kjos M, Diep DB.
PMID: 33573022
Antibiotics (Basel). 2021 Jan 29;10(2). doi: 10.3390/antibiotics10020131.

Staphylococci, like

Cite
Kranjec C, Morales Angeles D, Torrissen Mårli M, et al. Staphylococcal Biofilms: Challenges and Novel Therapeutic Perspectives. Antibiotics (Basel). 2021;10(2)doi: 10.3390/antibiotics10020131.
Kranjec, C., Morales Angeles, D., Torrissen Mårli, M., Fernández, L., García, P., Kjos, M., & Diep, D. B. (2021). Staphylococcal Biofilms: Challenges and Novel Therapeutic Perspectives. Antibiotics (Basel, Switzerland), 10(2), . https://doi.org/10.3390/antibiotics10020131
Kranjec, Christian, et al. "Staphylococcal Biofilms: Challenges and Novel Therapeutic Perspectives." Antibiotics (Basel, Switzerland) vol. 10,2 (2021). doi: https://doi.org/10.3390/antibiotics10020131
Kranjec C, Morales Angeles D, Torrissen Mårli M, Fernández L, García P, Kjos M, Diep DB. Staphylococcal Biofilms: Challenges and Novel Therapeutic Perspectives. Antibiotics (Basel). 2021 Jan 29;10(2). doi: 10.3390/antibiotics10020131. PMID: 33573022; PMCID: PMC7911828.
Copy Download .nbib Format: NLM
Showing 181 to 187 of 187 entries